NPI Portal NPI Lookup & Verification

Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Cancer Therapeutics Innovation Group

Clinical Medical Laboratory in New York, NY · enumerated 2011 · authorized official Petros Giannikopoulos, Partner.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1942505904

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)
Legal business name Cancer Therapeutics Innovation Group
Practice address 777 3rd Ave, Suite 14a, New York, NY, 10017
Phone (212) 355-3755
Enumeration date Jan 21, 2011
Last updated in NPPES Jun 25, 2013

Taxonomy & classification

291U00000X Clinical Medical Laboratory Laboratories · License 264295 (NY) Primary

Authorized official

Name Petros Giannikopoulos
Title Partner
Phone (212) 355-3755

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What is a Type 2 NPI?
A Type 2 NPI identifies an organization (group practice, hospital, pharmacy, lab), while Type 1 NPIs identify individual providers. Organizations bill under their Type 2 NPI.
What type of organization is Cancer Therapeutics Innovation Group?
Cancer Therapeutics Innovation Group is registered in NPPES as a Clinical Medical Laboratory (its primary provider taxonomy).

Providers at this address

Browse all →

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2013-06-25.